Krystal Biotech (KRYS) Raw Materials (2023 - 2026)

Krystal Biotech has disclosed Raw Materials across 4 years of filings, most recently posting $15.2 million for Q1 2026.

• Raw Materials for Q1 2026 came in at $15.2 million, changed 0.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.2 million (changed 0.22% YoY), and the FY2025 annual result was $15.9 million, up 16.86% from the prior year.
• Raw Materials came in at $15.2 million for Q1 2026 at Krystal Biotech, down from $15.9 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $15.9 million in Q4 2025 to a low of $3.2 million in Q4 2023.
• The 4-year median for Raw Materials is $13.8 million (2024), against an average of $11.1 million.
• Across the five-year window, Raw Materials jumped 332.44% in 2024 and gained 0.22% in 2026, its largest moves.
• Krystal Biotech's Raw Materials stood at $3.2 million in 2023, then surged by 332.44% to $13.6 million in 2024, then rose by 16.86% to $15.9 million in 2025, then declined by 4.8% to $15.2 million in 2026.
• The last three Raw Materials figures came in at $15.2 million (Q1 2026), $15.9 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.